Relugolix combination therapy for endometriosis pain

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (12)

• Gonadotrophin - releasing hormone analogues for endometriosis: bone mineral density via openalex
• Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density via openalex
• Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex
• Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
• Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
• O-132 Sustained efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT 52-week data via openalex
• Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) via openalex
• W4200280437 via openalex
• W2163315477 via openalex
• W2757350733 via openalex
• W2132577372 via openalex
• W6800149184 via openalex

Cited by (2)

• Oral GnRH Antagonists in Combination with Estradiol and Norethindrone Acetate for Pain Relief Associated with Endometriosis: A Review of Evidence of a Novel Class of Hormonal Agents 2024
• Managing the neuroinflammatory pain of endometriosis in light of chronic pelvic pain 2024

Source provenance

europepmc

last seen: 2026-06-14T06:08:20.186862+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-06-15T06:13:33.861732+00:00

unpaywall

last seen: 2026-06-13T06:42:57.164913+00:00